Found 500 news articles for
-
Million-dollar prize for team developing new vaginal reconstruction biomaterials
An international team developing new technologies for vaginal reconstruction has been awarded a prestigious million-dollar prize. Professor Caroline Gargett Hudson Institute’s Professor Caroline Gargett is the key international member of…… Read more
-
Combatting a killer – understanding what causes small cell lung cancer
A new understanding of the causes of small cell lung cancer (SCLC) could lead to more personalised treatments and lower mortality from this deadly disease. Dr Dan Gough In a…… Read more
-
Cataloguing brain cancer in children – Hudson Institute celebrates funding
An ambitious project to identify and characterise the rarest and deadliest forms of brain cancer in children has received a welcome funding boost. Thanks to a generous grant from the…… Read more
-
Neural stem cells may hold key to tackling newborn brain injury
Neural stem cells have strong potential to be effective in reducing brain injury in newborn babies, in the most extensive review of research on the topic. Injury to the brain…… Read more
-
Early intervention treatment for cerebral palsy shows promise despite sex differences
A promising early intervention treatment for cerebral palsy in newborn babies has proven effective in both boys and girls – even though it works differently depending on the sex of…… Read more
-
H.pylori vaccine research targets stomach cancer
A bacterium present in half the world’s population, Helicobacter pylori (h.pylori) is the target of new research aiming to develop a vaccine against stomach cancer. Professor Richard Ferrero H.pylori is a…… Read more
-
Making more effective and efficient RNA therapeutics
RNA technology developed by Hudson Institute of Medical Research with the potential to limit inflammatory side-effects of RNA therapeutics such as mRNA vaccines, is the subject of a new licensing…… Read more
-
Brain injury at birth – a better start for newborns
Newborn babies who suffer brain injury at birth could face significantly less risk of disability, thanks to a new treatment developed by Hudson Institute and Monash University scientists. Professor Suzanne…… Read more
-
2021 NHMRC Ideas Grants success
Hudson Institute has again been recognised in the awarding of NHMRC Ideas Grants to progress understanding to stomach lymphoma resulting from a Helicobacter pylori (H. pylori) infection and improving respiratory…… Read more
-
Flicking the inflammation off-switch
In a long-term collaboration between researchers and industry, an exciting first step has been made in the creation of a new generation of medicines for auto-immune diseases using one of…… Read more